vimarsana.com

Latest Breaking News On - Collegium pharmaceuticals - Page 1 : vimarsana.com

Collegium announces authorized generic agreement with Hikma for Nucynta, Nucynta ER

Hikma will have the exclusive right to sell the authorized generic versions of Nucynta and Nucynta ER in the United States.

Head-To-Head Contrast: Xenon Pharmaceuticals (NASDAQ:XENE) & Collegium Pharmaceutical (NASDAQ:COLL)

Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) and Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Risk and Volatility Xenon Pharmaceuticals has a beta […]

Collegium Pharmaceutical, Inc (NASDAQ:COLL) Q3 2023 Earnings Call Transcript

Form S-1/A Chromocell Therapeutics

Form S-1/A Chromocell Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.